Drug Database
HO

hormone patches (Lyrelle / Lyrelle 50 / Lyrelle 80)

✓ Approved

Shire · ESR1 · 小分子

什么是 hormone patches?

hormone patches 是一种小分子,由Shire研发。该药已获批,用于治疗相关适应症,给药途径:Transdermal。

药物档案

商品名Lyrelle, Lyrelle 50, Lyrelle 80
公司Shire
药物类别小分子
分子靶点ESR1, PGR
给药途径Transdermal
状态Approved

作用机制

分子靶点

hormone patches 作用于 2 个分子靶点:

ESR1estrogen receptor 1 (ER, ESR)
PGRprogesterone receptor (NR3C3, PR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

hormone patches 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresHormone replacement therapy✓ Approved

相关研究文献

PubMedMethods in molecular biology (Clifton, N.J.)2026-11-19

The Transformative Role of Artificial Intelligence in Wearable Health Monitoring: Applications in Diagnosis, Therapy, and Rehabilitation.

Shen Xiangru X, Luo Xuefeng X, Sun Yinsong Y, Zhu Zhenglin Z et al.

This chapter explores the transformative impact of artificial intelligence (AI)-augmented wearable technology in dynamic health monitoring across diagnosis, treatment, and rehabilitation. Innovations include real-time cardiovascular disease detection, AI-driven continuous glucose monitoring for diabetes, and neurological disorder tracking using flexible electroencephalograph (EEG) sensors. Therapeutic advances feature smart drug-delivery patches responsive to biomarkers, remote intervention systems, and surgical tools like augmented reality (AR) navigation. Rehabilitation breakthroughs encompass wearables for motor recovery, cardiopulmonary optimization, and neurorehabilitation using brain-computer interfaces. Future progress hinges on multifunctional hardware, federated learning for privacy, explainable AI, and standardized regulations.

PMID 43052671
阅读全文 →
PubMedInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026-11-19

Response: Association between type and duration of menopausal hormone therapy and endometrial cancer risk: A population-based study.

Yoon Sang-Hee SH, Yuk Jin-Sung JS

PMID 43053549
阅读全文 →
PubMedInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026-11-19

Letter to the Editor: Association between type and duration of menopausal hormone therapy and endometrial cancer risk: A population-based study.

Liu Jingmeng J, Wang Lidong L

PMID 43053522
阅读全文 →
PubMedNature methods2026-11-19

A zero-shot spillover denoiser for highly multiplexed images.

Lequyer Jason J, Nowlan Ferris F, Hsu Wen-Hsin WH, Philip Reuben R et al.

Highly multiplexed imaging techniques are an important part of the biological analysis toolkit. However, the resulting images can suffer from considerable noise and spillover. Because accurately correcting spillover normally requires additional wet-lab experiments to determine how the channels interact with each other, here we present SpillOT, a purely computational zero-shot denoising and spillover correction tool that operates in an unsupervised manner, learning solely from the input image without the need for additional experiments or representative training datasets. SpillOT uses optimal transport theory to identify similar patches across channels and retain only the true signal. We demonstrate that SpillOT surpasses existing zero-shot image restoration techniques and markedly improves the reliability and precision of downstream analyses on Imaging Mass Cytometry, Tissue Cyclic immunofluorescence and Opal multiplexed immunofluorescence datasets. We also show that using SpillOT, we can find previously undetectable immune infiltration patterns in diabetes data. We release SpillOT as both a standalone script and a Fiji plugin.

PMID 43052455
阅读全文 →
PubMedScientific data2026-11-19

A multi-center annotated oral cytology dataset for AI-assisted early detection of oral squamous cell carcinoma.

Jain Garima G, Patil Abhijeet A, Goel Poonam P, Pati Sanghamitra S et al.

Oral squamous cell carcinoma is a major public health burden, particularly in regions with limited access to specialist pathology services. Oral brush cytology provides a minimally invasive approach for screening and early assessment, but the development of automated analysis methods requires well-annotated, multi-source datasets. We present a multicenter oral cytology dataset collected from tertiary medical centers in India. The dataset includes Papanicolaou- and May-Grünwald-Giemsa-stained whole-slide images, associated patient- and slide-level metadata, high-resolution image patches, and expert-verified nucleus-level annotations in QuPath-compatible GeoJSON format. The annotations support computational tasks including nucleus segmentation, instance segmentation, and cytological category classification. Dataset-level validation checks are provided to document file completeness, metadata consistency, annotation integrity, patch-to-slide linkage, and reuse readiness. The dataset is intended to facilitate development and benchmarking of computational pathology methods for oral cytology analysis.

PMID 43052319
阅读全文 →
PubMedInternational journal of transgender health2026-11-19

Current status and characteristics of self-medication with gender-affirming hormones among individuals with gender dysphoria in China.

Cai Yueting Y, Chang Xu X, Dong Yulin Y, Li Rucan R et al.

Gender-affirming hormone therapy (GAHT) is an effective treatment for gender dysphoria. However, a substantial proportion of transgender individuals resort to self-medication with hormones. This study aimed to investigate the current status, characteristics, and associated factors of self-medication among individuals with gender dysphoria in China. In this cross-sectional study, data were collected from the Gender Clinic of Peking University Third Hospital between January 2016 and November 2024. Demographic information, hormone treatment history, laboratory test results, scores from the 7-item Generalized Anxiety Disorder Scale (GAD-7), and scores from the 9-item Patient Health Questionnaire (PHQ-9) were analyzed. Among 826 transgender individuals with gender dysphoria, 60.4% had self-medicated before their clinic visit, with 85.4% obtaining hormones from nonmedical sources. The average age at first use was 20.1 years, and the youngest user was 10 years old. The proportion of transgender women was significantly higher in the self-medication group than that in the no self-medication group (90.4% vs. 59.3%, p < 0.001). Multivariate analysis identified being a transgender woman (OR 6.10, 95% CI 4.17-8.95) and the use of psychotropic medications (OR 1.36, 95% CI 1.00-1.86) as independent factors associated with self-medication. No significant differences in GAD-7 or PHQ-9 scores were observed between the two groups. Informal self-medication with GAHT is highly prevalent among transgender individuals in China. Identifying as a transgender woman and using psychotropic medications were independent risk factors associated with self-medication behavior. These findings highlight the need for improved health education and the development of standardized hormone distribution systems to reduce potential risks.

PMID 43053749
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多hormone patches